Since 2014

• » Report OsMed related to the first nine months of 2011
  
  Bandi, Ombretta
  2011-12-21
  View Record | View Original
• » L’analisi delle decisioni negli studi di farmacoeconomia
  
  Bacchieri, Antonella; Attanasio, Ermanno
  2005-06-15
  View Record | View Original
• » Valutazione dei costi di trattamento dei disturbi psicotici con olanzapina, risperidone...
  
  Rossi, I.; Guidi, L.
  2001-12-15
  View Record | View Original
• » [Budget impact analysis of idarucizumab for the management of patients treated with...
  
  Belisari, Andrea; Iannazzo, Sergio; Di Pasquale, Giuseppe; Fresco, Claudio; Mantovani, Lorenzo Giovanni; Ruggeri, Maria Pia; Toni, Danilo; Landolfi, Raffaele
  2016-06-28
  View Record | View Original
• » Evaluation of health resources expenditure in two groups of psychotic patients treated...
  
  Caputo, Anna; Guidi, Luca; Biricolti, Giovanni; Torchia, Sergio
  2008-03-15
  View Record | View Original
• » Appendice
  
  Cavallo, Maria Caterina; Cipriani, Filippo; Gerzeli, Simone; Demarteau, Nadia; Marocco, Alessia; Bamfi, Francesco
  2008-09-15
  View Record | View Original
• » Telithromycin (Ketek®)in lower respiratory tract infections: economic aspects
  
  Lazzaro, Carlo
  2006-09-15
  View Record | View Original
• » Pharmacoeconomic evaluation of influenza vaccination programs in elderly in Italy
  
  Iannazzo, Sergio; Sacchi, Viola
  2009-06-15
  View Record | View Original

51 - 58 of 58 Items    << < 1 2 3